Publications by authors named "L Fulger"

Background/objectives: This systematic review aimed to evaluate the outcomes of minimally invasive techniques in gynecological cancer surgery, specifically laparoscopic hysterectomies (LHs), robotic-assisted hysterectomies (RHs), and laparoscopic-assisted vaginal hysterectomies (LAVHs).

Methods: We conducted a comprehensive search of electronic databases including PubMed and MedLine from January 2010 to August 2024. The search included randomized controlled trials (RCTs) and observational studies.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how preoperative inflammatory markers (like NLR, PLR, APRI, and SII) and liver function tests can predict the risk of developing fistulas after colorectal cancer surgery.
  • Conducted at the "Pius Brinzeu" Clinical Emergency Hospital with data from 219 patients, the findings highlight that the Systemic Inflammation Index (SII) and albumin levels are particularly effective in predicting fistula risk.
  • The research emphasizes that using these biomarkers for preoperative assessments can help doctors stratify risks and improve surgical outcomes for colorectal cancer patients.
View Article and Find Full Text PDF

This systematic review critically evaluates the impact of systemic treatments on outcomes and quality of life (QoL) in patients with RAS-positive stage IV colorectal cancer, with studies published up to December 2023 across PubMed, Scopus, and Web of Science. From an initial pool of 1345 articles, 11 relevant studies were selected for inclusion, encompassing a diverse range of systemic treatments, including panitumumab combined with FOLFOX4 and FOLFIRI, irinotecan paired with panitumumab, regorafenib followed by cetuximab ± irinotecan and vice versa, and panitumumab as a maintenance therapy post-induction. Patient demographics predominantly included middle-aged to elderly individuals, with a slight male predominance.

View Article and Find Full Text PDF

The global pandemic period from 2020 to 2022 caused important alterations in oncology care. This study aimed to describe the trends and variations in patient characteristics, comorbidities, and treatment approaches during this time in Romania. We conducted a retrospective database search to identify patients with rectal cancer who underwent surgical intervention between 2020 and 2022 and the year 2019, which served as a pre-pandemic period control.

View Article and Find Full Text PDF

Anal fistulas often cause significant impairment to patients' health-related quality of life (HRQOL). This cross-sectional study aimed to compare the HRQOL between patients with anal fistulas with inflammatory bowel disease (IBD) and those without, hypothesizing significant differences in HRQOL scores between these groups. The secondary objectives were to identify specific aspects of life quality most affected and explore potential variables influencing HRQOL.

View Article and Find Full Text PDF